Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.

Matissek KJ, Onozato ML, Sun S, Zheng Z, Schultz A, Lee J, Patel K, Jerevall PL, Saladi SV, Macleay A, Tavallai M, Badovinac-Crnjevic T, Barrios C, Beşe N, Chan A, Chavarri-Guerra Y, Debiasi M, Demirdögen E, Egeli Ü, Gökgöz S, Gomez H, Liedke P, Tasdelen I, Tolunay S, Werutsky G, St Louis J, Horick N, Finkelstein DM, Le LP, Bardia A, Goss PE, Sgroi DC, Iafrate AJ, Ellisen LW.

Cancer Discov. 2018 Mar;8(3):336-353. doi: 10.1158/2159-8290.CD-17-0535. Epub 2017 Dec 14.

2.

Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.

Cecene G, Ak S, Eskiler GG, Demirdogen E, Erturk E, Gokgoz S, Polatkan V, Egeli U, Tunca B, Tezcan G, Topal U, Tolunay S, Tasdelen I.

Asian Pac J Cancer Prev. 2016;17(9):4241-4246.

3.

Association of PALB2 sequence variants with the risk of early-onset breast cancer in patients from Turkey.

Cecener G, Guney Eskiler G, Egeli U, Tunca B, Alemdar A, Gokgoz S, Tasdelen I.

Mol Biol Rep. 2016 Nov;43(11):1273-1284. Epub 2016 Aug 29.

PMID:
27573125
4.

Expression and clinical significance of miRNAs that may be associated with the FHIT gene in breast cancer.

Sevinc ED, Cecener G, Ak S, Tunca B, Egeli U, Gokgoz S, Tolunay S, Tasdelen I.

Gene. 2016 Sep 30;590(2):278-84. doi: 10.1016/j.gene.2016.05.033. Epub 2016 May 25.

PMID:
27236032
5.

Nasogastric tube placement into the hepaticojejunostomy anastomosis in pancreaticoduodenectomy: a simple surgical technique for prevention of bile leak.

Kaya B, Ozcabi Y, Tasdelen I, Onur E, Memisoglu K.

Korean J Hepatobiliary Pancreat Surg. 2016 May;20(2):89-92. doi: 10.14701/kjhbps.2016.20.2.89. Epub 2016 May 11.

6.

Gestational Gigantomastia.

Türkan H, Gökgöz MŞ, Taşdelen İ, Dündar HZ.

J Breast Health. 2016 Apr 1;12(2):86-87. doi: 10.5152/tjbh.2016.2852. eCollection 2016 Apr.

7.

Association of miR-1266 with recurrence/metastasis potential in estrogen receptor positive breast cancer patients.

Sevinc ED, Egeli U, Cecener G, Tezcan G, Tunca B, Gokgoz S, Tasdelen I, Tolunay S, Evrensel T.

Asian Pac J Cancer Prev. 2015;16(1):291-7.

8.

BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer.

Erturk E, Cecener G, Tezcan G, Egeli U, Tunca B, Gokgoz S, Tolunay S, Tasdelen I.

Gene. 2015 Feb 10;556(2):163-9. doi: 10.1016/j.gene.2014.11.047. Epub 2014 Nov 22.

PMID:
25445393
9.

Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.

Erturk E, Cecener G, Polatkan V, Gokgoz S, Egeli U, Tunca B, Tezcan G, Demirdogen E, Ak S, Tasdelen I.

Asian Pac J Cancer Prev. 2014;15(19):8319-24.

10.

Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies.

Ozmen V, Boylu S, Ok E, Canturk NZ, Celik V, Kapkac M, Girgin S, Tireli M, Ihtiyar E, Demircan O, Baskan MS, Koyuncu A, Tasdelen I, Dumanli E, Ozdener F, Zaborek P.

Eur J Public Health. 2015 Feb;25(1):9-14. doi: 10.1093/eurpub/cku086. Epub 2014 Aug 5.

11.

Expression status of let-7a and miR-335 among breast tumors in patients with and without germ-line BRCA mutations.

Erturk E, Cecener G, Egeli U, Tunca B, Tezcan G, Gokgoz S, Tolunay S, Tasdelen I.

Mol Cell Biochem. 2014 Oct;395(1-2):77-88. doi: 10.1007/s11010-014-2113-4. Epub 2014 Jun 19.

PMID:
24942235
12.

BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patients.

Cecener G, Egeli U, Tunca B, Erturk E, Ak S, Gokgoz S, Tasdelen I, Tezcan G, Demirdogen E, Bayram N, Avci N, Evrensel T.

Cancer Invest. 2014 Oct;32(8):375-87. doi: 10.3109/07357907.2014.919302. Epub 2014 Jun 2.

PMID:
24884828
13.
14.

Early adipogenesis is regulated through USP7-mediated deubiquitination of the histone acetyltransferase TIP60.

Gao Y, Koppen A, Rakhshandehroo M, Tasdelen I, van de Graaf SF, van Loosdregt J, van Beekum O, Hamers N, van Leenen D, Berkers CR, Berger R, Holstege FC, Coffer PJ, Brenkman AB, Ovaa H, Kalkhoven E.

Nat Commun. 2013;4:2656. doi: 10.1038/ncomms3656.

PMID:
24141283
15.

PPARγ regulates expression of carbohydrate sulfotransferase 11 (CHST11/C4ST1), a regulator of LPL cell surface binding.

Tasdelen I, Berger R, Kalkhoven E.

PLoS One. 2013 May 16;8(5):e64284. doi: 10.1371/journal.pone.0064284. Print 2013.

16.

The serine/threonine phosphatase PPM1B (PP2Cβ) selectively modulates PPARγ activity.

Tasdelen I, van Beekum O, Gorbenko O, Fleskens V, van den Broek NJ, Koppen A, Hamers N, Berger R, Coffer PJ, Brenkman AB, Kalkhoven E.

Biochem J. 2013 Apr 1;451(1):45-53. doi: 10.1042/BJ20121113.

PMID:
23320500
17.

CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer.

Tunca B, Egeli U, Cecener G, Tezcan G, Gökgöz S, Tasdelen I, Bayram N, Tolunay S, Umut G, Demirdogen E, Erturk E, Ak S, Cetintas S, Evrensel T.

Tumori. 2012 Mar-Apr;98(2):243-51. doi: 10.1700/1088.11937.

PMID:
22677992
18.

Altered plasma adipokine levels and in vitro adipocyte differentiation in pediatric type 1 diabetes.

Verrijn Stuart AA, Schipper HS, Tasdelen I, Egan DA, Prakken BJ, Kalkhoven E, de Jager W.

J Clin Endocrinol Metab. 2012 Feb;97(2):463-72. doi: 10.1210/jc.2011-1858. Epub 2011 Nov 23.

PMID:
22112811
19.

Regulation of expression and secretion of galectin-3 in human monocyte-derived dendritic cells.

van Stijn CM, van den Broek M, van de Weerd R, Visser M, Taşdelen I, Tefsen B, van Die I.

Mol Immunol. 2009 Oct;46(16):3292-9. doi: 10.1016/j.molimm.2009.07.026. Epub 2009 Aug 21.

PMID:
19699526
20.

The effect of distance on the postoperative follow-up of patients with breast carcinoma.

Kirdak T, Paksoy E, Sigirli D, Tasdelen I, Gokgoz S.

Acta Chir Belg. 2008 Jan-Feb;108(1):93-7.

PMID:
18411581
21.

Importance of novel sequence alterations in the FHIT gene on formation of breast cancer.

Ceçener G, Egeli U, Tunca B, Taşdelen I, Tolunay S, Bilgel N.

Tumori. 2007 Nov-Dec;93(6):597-603.

PMID:
18338496
22.

Breast and osteoarticular tuberculosis in a male patient.

Ursavaş A, Ege E, Bilgen OF, Taşdelen I, Coskun F, Sönmez S, Gözü RO.

Diagn Microbiol Infect Dis. 2007 Aug;58(4):477-9. Epub 2007 May 16.

PMID:
17509793
23.

Factors influencing axillary node metastasis in breast cancer.

Cetintaş SK, Kurt M, Ozkan L, Engin K, Gökgöz S, Taşdelen I.

Tumori. 2006 Sep-Oct;92(5):416-22.

PMID:
17168435
24.

Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.

Egeli U, Cecener G, Tunca B, Tasdelen I.

Cancer Invest. 2006 Aug-Sep;24(5):484-91.

PMID:
16939956
25.

Synchronous breast cancer in spouses.

Kahraman-Cetintaş S, Kurt M, Gökgöz S, Ozkan L, Engin K, Taşdelen I.

Tumori. 2006 May-Jun;92(3):244-5.

PMID:
16869244
26.

Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure.

Demiray M, Kurt E, Evrensel T, Kanat O, Arslan M, Saraydaroglu O, Ercan I, Gonullu G, Gokgoz S, Topal U, Tolunay S, Tasdelen I, Manavoglu O.

Cancer Invest. 2005;23(5):386-91.

PMID:
16193637
27.

Role of ultrasound-guided core needle biopsy of axillary lymph nodes in the initial staging of breast carcinoma.

Topal U, Punar S, Taşdelen I, Adim SB.

Eur J Radiol. 2005 Dec;56(3):382-5. Epub 2005 Jul 15.

PMID:
16024205
28.

Acquired lymphangiectasis after breast conservation treatment for breast cancer: report of a case.

Tasdelen I, Gokgoz S, Paksoy E, Yerci O, Cetintas SK, Demiray M, Samsa V.

Dermatol Online J. 2004 Jul 15;10(1):9. Review.

29.

Factors influencing cosmetic results after breast conserving management (Turkish experience).

Cetintaş SK, Ozkan L, Kurt M, Saran A, Taşdelen I, Tolunay S, Topal U, Engin K.

Breast. 2002 Feb;11(1):72-80.

PMID:
14965649
30.

Primary neuroendocrine small cell carcinoma of the breast.

Samli B, Celik S, Evrensel T, Orhan B, Tasdelen I.

Arch Pathol Lab Med. 2000 Feb;124(2):296-8.

PMID:
10656743
31.

Common fragile site expression and genetic predisposition to breast cancer.

Ceçener G, Egeli U, Taşdelen I, Tunca B, Duman H, Kizil A.

Teratog Carcinog Mutagen. 1998;18(6):279-91.

PMID:
10052563
32.

Traumatic asphyxia in children.

Sarihan H, Abes M, Akyazici R, Cay A, Imamoglu M, Tasdelen I, Imamoglu I.

J Cardiovasc Surg (Torino). 1997 Feb;38(1):93-5.

PMID:
9128131
33.

Blunt thoracic trauma in children.

Sarihan H, Abes M, Akyazici R, Cay A, Imamoglu M, Tasdelen I.

J Cardiovasc Surg (Torino). 1996 Oct;37(5):525-8.

PMID:
8941697

Supplemental Content

Loading ...
Support Center